Literature DB >> 4325310

Inhibition of antigodies binding polyinosinic-polycytidylic acid in human and mouse lupus sera by viral and synthetic ribonucleic acids.

N Talal, A D Steinberg, G G Daley.   

Abstract

The specificities of anti-RNA antibodies of diverse origin were studied by inhibition of the binding of radioative polyinosinic polycytidylic acid. The antibodies were from human patients with systemic lupus erythematosus (SLE), older NZB/NZW F(1) mice who have SLE, and young NZB/NZW F(1) mice immunized with either synthetic or viral double-stranded (ds) RNA. The inhibitors were two viral ds and two synthetic ds RNAs, ribosomal RNA and transfer RNA. The human sera were more heterogeneous than the mouse lupus sera, and had greatest specificity for reovirus RNA. The mouse lupus sera were more homogeneous and, in general, were inhibited efficiently by all four ds RNAs. Sera from mice immunized with synthetic RNA reacted poorly with viral RNA, whereas sera from mice immunized with viral RNA reacted with all four ds RNAs and resembled the lupus sera. These results suggest a role for viruses in the induction of anti-RNA antibodies, and are compatible with the concept that virus infection as well as excessive antibody responses are involved in the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4325310      PMCID: PMC292054          DOI: 10.1172/JCI106602

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Myxovirus antibody increases in human connective tissue disease.

Authors:  P E Phillips; C L Christian
Journal:  Science       Date:  1970-05-22       Impact factor: 47.728

2.  [Antigenicity of polynucleotide complexes].

Authors:  E Nahon; A M Michelson; F Lacour
Journal:  Biochim Biophys Acta       Date:  1967-11-21

3.  Endothelial inclusions in active lesions of systemic lupus erythematosus.

Authors:  W L Norton
Journal:  J Lab Clin Med       Date:  1969-09

4.  Systemic lupus erythematosus and myxovirus.

Authors:  F Györkey; K W Min; J G Sincovics; P Györkey
Journal:  N Engl J Med       Date:  1969-02-06       Impact factor: 91.245

5.  Measurement of serum DNA-binding activity in systemic lupus erythematosus.

Authors:  T Pincus; P H Schur; J A Rose; J L Decker; N Talal
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

6.  Immunochemical measurement of double-stranded RNA of uninfected and arbovirus-infected mammalian cells.

Authors:  V Stollar; B D Stollar
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

7.  Antibodies to polynucleotides: distribution in human serums.

Authors:  D Koffler; R I Carr; V Agnello; T Fiezi; H G Kunkel
Journal:  Science       Date:  1969-12-26       Impact factor: 47.728

8.  Antibodies to ribonucleic acid in systemic lupus erythematosus.

Authors:  P H Schur; M Monroe
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

9.  The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.

Authors:  A D Steinberg; S Baron; N Talal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

10.  Further implication of murine leukemia-like virs in the disorders of NZB mice.

Authors:  R C Mellors; T Aoki; R J Huebner
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  13 in total

1.  Independent appearance of anti-thymocyte and anti-RNA antibodies in NZB/NZW F1 mice.

Authors:  R Goldblum; R Pillarisetty; N Talal
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

2.  Acceleration of autoimmunity in NZB/NZW F1 mice by graft-versus-host disease.

Authors:  R Goldblum; R Pillarisetty; M J Dauphinee; N Talal
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

Review 3.  B-cell epitopes of RNA autoantigens.

Authors:  R M Hoet; W J van Venrooij
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

4.  Presence of hepatitis-associated antigen in systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; E Fishbein; E Díaz-Jouanen
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

5.  Antibodies binding polyriboadenylic acid in systemic lupus erythematosus. Immunochemical characterization and isolation by affinity chromatography.

Authors:  R J Pillarisetty; M J Becker; D W Palmer; N Talal
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

6.  Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies.

Authors:  R J DeHoratius; R Pillarisetty; R P Messner; N Talal
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

7.  Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.

Authors:  A D Bankhurst; R C Williams
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

8.  Antibodies to polyadenylic acid in patients with myasthenia gravis.

Authors:  M Fischbach; J Lindstrom; N Talal
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

9.  An unusual mouse myeloma protein binding native DNA.

Authors:  J A Dixon; S Sugai; N Talal
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

10.  Studies on autoantibodies to poly (adenosine diphosphate-ribose) in SLE and other autoimmune diseases.

Authors:  W J Morrow; D A Isenberg; H F Parry; L Shen; E E Okolie; F Farzaneh; S Shall; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.